Broad Institute Wins $50M Commitment toward Early-Stage Drug Research

The Broad Institute of MIT and Harvard will receive more than $50 million from the healthcare-focused investment management firm Deerfield Management, through a partnership designed to translate early-stage research into new therapeutics for serious unmet medical needs.Deerfield, which manages approximately $8 billion in funds, has agreed to fund early-stage academic research at the Broad over an initial five-year period. Deerfield also agreed to provide “significant additional resources&r